Publications des scientifiques de l'IRD

Bouzinbi N., Marcy O., Bertolotti T., Chiron R., Bemer P., Pestel-Caron M., Peuchant O., Guet-Revillet H., Fangous M. S., Hery-Arnaud G., Ouedraogo A. S., Banuls Anne-Laure, Godreuil S. (2020). Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex. PLoS One, 15 (9), p. e0239146 [5 p.]. ISSN 1932-6203.

Titre du document
Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex
Année de publication
2020
Type de document
Article référencé dans le Web of Science WOS:000576266600042
Auteurs
Bouzinbi N., Marcy O., Bertolotti T., Chiron R., Bemer P., Pestel-Caron M., Peuchant O., Guet-Revillet H., Fangous M. S., Hery-Arnaud G., Ouedraogo A. S., Banuls Anne-Laure, Godreuil S.
Source
PLoS One, 2020, 15 (9), p. e0239146 [5 p.] ISSN 1932-6203
The first objective of this study was to determine the GenoType NTM-DR assay performance for subspecies identification in Mycobacterium abscessus complex isolates. The second objective was to evaluate the GenoType NTM-DR assay ability to detect clarithromycin and amikacin resistance in M.abscessus complex isolates compared with drug susceptibility testing (DST) and PCR sequencing of the erm(41),rrl and rrs genes. The concordance between the GenoType NTM-DR and MLST results concerning subspecies identification was 100%. The wild type and mutated alleles of the rrlandrrs genes were detected by the GenoType NTM-DR assay and PCR sequencing with 100% (115/115) agreement. Similarly, 100% concordance between GenoType NTM-DR and DST was observed for clarithromycin and amikacin testing. Sensitivity for the detection of clarithromycin and amikacin resistance was 100%. The GenoType NTM-DR assay provides a robust and complementary tool to the gold standard methods (MLST and broth microdilution) for subspecies identification and drug resistance detection.
Plan de classement
Sciences fondamentales / Techniques d'analyse et de recherche [020] ; Santé : généralités [050] ; Biotechnologies [084]
Localisation
Fonds IRD [F B010079832]
Identifiant IRD
fdi:010079832
Contact